Auxier Asset Management Bristol Myers Squibb CO Transaction History

Auxier Asset Management

$628 Million
Q2 2024

A detailed history of Auxier Asset Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Auxier Asset Management holds 24,546 shares of BMY stock, worth $1.31 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

24,546

Previous 25,170 2.48%

Holding current value

$1.31 Million

Previous $1.36 Million 25.29%

% of portfolio

0.16%

Previous 0.21%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $25,116 - $33,065	-624 Reduced 2.48%	24,546 $1.02 Million
Q1 2024 May 08, 2024	SELL	$47.98 - $54.4 $76,959 - $87,257	-1,604 Reduced 5.99%	25,170 $1.36 Million
Q4 2023 Feb 22, 2024	SELL	$48.48 - $57.85 $99,335 - $118,534	-2,049 Reduced 7.11%	26,774 $1.37 Million
Q3 2023 Nov 21, 2023	SELL	$57.89 - $64.73 $2,894 - $3,236	-50 Reduced 0.17%	28,823 $1.67 Million
Q2 2023 Aug 17, 2023	SELL	$63.71 - $70.74 $4,714 - $5,234	-74 Reduced 0.26%	28,873 $1.85 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $19,712 - $22,359	-300 Reduced 1.03%	28,947 $2.01 Million
Q3 2022 Nov 15, 2022	SELL	$0.13 - $76.84 $110 - $65,237	-849 Reduced 2.82%	29,247 $2.08 Million
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $72,547 - $79,900	-999 Reduced 3.21%	30,096 $2.32 Million
Q1 2022 May 17, 2022	BUY	$61.48 - $73.72 $4,611 - $5,529	75 Added 0.24%	31,095 $2.27 Million
Q4 2021 Mar 01, 2022	BUY	$53.63 - $62.52 $53 - $62	1 Added 0.0%	31,020 $1.93 Million
Q3 2021 Nov 18, 2021	SELL	$59.17 - $69.31 $2,899 - $3,396	-49 Reduced 0.16%	31,019 $1.84 Million
Q2 2021 Aug 18, 2021	SELL	$61.91 - $67.42 $33,369 - $36,339	-539 Reduced 1.71%	31,068 $2.08 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $23,854 - $26,829	-402 Reduced 1.26%	31,607 $2 Million
Q4 2020 Mar 05, 2021	BUY	$57.74 - $65.43 $841,271 - $953,315	14,570 Added 83.55%	32,009 $1.99 Million
Q3 2020 Mar 05, 2021	BUY	$57.43 - $63.64 $70,811 - $78,468	1,233 Added 7.61%	17,439 $1.05 Million
Q2 2020 Aug 20, 2020	BUY	$54.82 - $64.09 $503,302 - $588,410	9,181 Added 130.69%	16,206 $953,000
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $29,928 - $43,492	645 Added 10.11%	7,025 $392,000
Q4 2019 Feb 21, 2020	BUY	$49.21 - $64.19 $15,304 - $19,963	311 Added 5.12%	6,380 $410,000
Q3 2019 Nov 15, 2019	BUY	$42.77 - $50.71 $6,415 - $7,606	150 Added 2.53%	6,069 $308,000
Q2 2019 Aug 15, 2019	BUY	$44.62 - $49.34 $3,346 - $3,700	75 Added 1.28%	5,919 $268,000
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $54,144 - $64,560	-1,200 Reduced 17.04%	5,844 $279,000
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $10,971 - $14,226	-225 Reduced 3.1%	7,044 $366,000
Q2 2018 Aug 15, 2018	SELL	$50.53 - $62.98 $6,265 - $7,809	-124 Reduced 1.68%	7,269 $402,000
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $59,920 - $68,980	1,000 Added 15.64%	7,393 $468,000
Q2 2017 Aug 16, 2017	BUY	N/A	6,393	6,393 $356,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Auxier Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Auxier Asset Management with notifications on news.

Account

Auxier Asset Management Bristol Myers Squibb CO Transaction History